Market size, growth to 2033 and clinical trials, side by side.
China is the bigger Angioplasty Balloons market: $326 Mn against $74 Mn in 2023, about 4.4 times as large.
India grows faster: 6.8% a year, against 5.3%. The gap still grows from $253 Mn to $404 Mn by 2033.
Clinical research: 103 active trials in China, 1 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $326 Mn | $74 Mn |
| Market size, 2033 projected | $547 Mn | $143 Mn |
| Growth a year (CAGR) | 5.3% | 6.8% |
| Money added, 2023–2033 | $221 Mn | $69 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.23 | $0.05 |
| Active clinical trials | 103 | 1 |
| Full report | China report | India report |
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
China is the bigger Angioplasty Balloons market: $326 Mn against $74 Mn in 2023, about 4.4 times as large.
India grows faster: 6.8% a year, against 5.3%. The gap still grows from $253 Mn to $404 Mn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.